Cargando…
Rapamycin Synergizes with Cisplatin in Antiendometrial Cancer Activation by Improving IL-27–Stimulated Cytotoxicity of NK Cells
Natural killer (NK) cell function is critical for controlling initial tumor growth and determining chemosensitivity of the tumor. A synergistic relationship between rapamycin and cisplatin in uterine endometrial cancer (UEC) in vitro has been reported, but the mechanism and the combined therapeutic...
Autores principales: | Zhou, Wen-Jie, Chang, Kai-Kai, Wu, Ke, Yang, Hui-Li, Mei, Jie, Xie, Feng, Li, Da-Jin, Li, Ming-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724748/ https://www.ncbi.nlm.nih.gov/pubmed/29195127 http://dx.doi.org/10.1016/j.neo.2017.11.003 |
Ejemplares similares
-
NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma
por: Huang, Jin-Cheng, et al.
Publicado: (2017) -
Effect of combination of rapamycin and cisplatin on human cervical carcinoma Hela cells
por: Han, Lu, et al.
Publicado: (2013) -
IL-27 triggers IL-10 production in Th17 cells via a c-Maf/RORγt/Blimp-1 signal to promote the progression of endometriosis
por: Chang, Kai-Kai, et al.
Publicado: (2017) -
Synergic Effect of α-Mangostin on the Cytotoxicity of Cisplatin in a Cervical Cancer Model
por: Pérez-Rojas, Jazmin M., et al.
Publicado: (2016) -
The ferroptosis inducer erastin irreversibly inhibits system x(c)− and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells
por: Sato, Mami, et al.
Publicado: (2018)